查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1800144

全球寵物疫苗市場：2025 年至 2030 年預測

Global Pet Vaccine Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計寵物疫苗市場規模到2025年將達到14,260億美元，到2030年將達到19,250億美元，複合年成長率為6.19%。

受寵物擁有率上升、寵物健康意識增強以及通用感染疾病日益流行的推動，寵物疫苗市場可望穩定成長。寵物疫苗對於維持動物免疫力和保護社區健康（尤其是預防狂犬病等疾病）至關重要。技術進步、政府扶持措施以及不斷增加的研發投入正在進一步推動市場擴張。犬用疫苗市場，尤其是注射疫苗，由於其在預防感染疾病的有效性，預計將實現顯著成長。

市場成長動力

寵物擁有量的增加和疾病的傳播

寵物擁有量的激增，尤其是在千禧世代中，推動了寵物疫苗的需求，因為飼主更加重視寵物的健康。狂犬病等通用感染疾病的爆發凸顯了定期接種疫苗的必要性。狂犬病主要由犬類傳播，仍是全球主要的健康隱患，在東南亞等地區發病率較高。疫苗在預防此類疾病方面的有效性，加上公眾意識的不斷提高和動物福利宣傳活動的發展，正在推動市場成長。

技術進步和政府支持

疫苗研發的技術創新正在提高疫苗的有效性和安全性，並支持其市場推廣。政府採取的積極舉措，包括補貼和意識提升活動，正在鼓勵寵物疫苗接種，尤其是在疾病負擔較高的地區。不斷增加的研發支出正在支持先進疫苗的引進，以應對新出現的健康挑戰並擴大市場潛力。人們對皮下或肌肉注射疫苗的日益關注，凸顯了疫苗在刺激強大免疫反應方面的作用，並已成為獸醫學的基石。

犬用疫苗市場的擴張

預計犬用疫苗產業將迎來顯著成長，這主要得益於對抗狂犬病、犬小病毒和鉤端螺旋體病等常見疾病的需求。注射疫苗旨在預防傳染性病原體，因其可靠且易於獸醫專業人員使用而廣泛應用。全球對狂犬病疫苗的需求，尤其是在中低收入國家，進一步推動了該產業的發展，聯合國兒童基金會等組織也確保了疫苗的可負擔供應。

地理視角

美國憑藉其龐大的寵物數量和高寵物擁有率（尤其是在千禧世代家庭中）在北美寵物疫苗市場佔據主導地位。美國對寵物健康的重視，加上自身對人類健康改善等益處，支撐了疫苗的需求。龐大的犬貓種群使得定期接種疫苗成為必需，從而催生了強勁的市場。加拿大等其他北美國家也透過不斷成長的寵物擁有量和寵物意識做出了貢獻。預計亞太地區將迎來快速成長，這得益於印度和中國等國寵物擁有量的成長以及政府推出的健康計劃。

寵物疫苗市場預計將穩定成長，這得益於寵物主人數量的增加、通用感染疾病的流行以及疫苗技術的進步。犬用疫苗，尤其是注射疫苗，因其在疾病預防中的重要角色而引領市場。雖然美國仍然是領先的市場，但亞太地區顯示出強勁的成長潛力。政府的支持和研發投入進一步提升了市場前景。寵物健康意識的增強將推動對有效疫苗的需求，從而推動市場持續擴張。

本報告的主要優點

  • 深入分析：深入了解主要和新興地區的市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局：了解主要企業採用的策略策略，並了解正確策略的市場滲透潛力。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力進行策略決策並在動態環境中開闢新的業務流和收益。
  • 適合廣泛的使用者：對於新興企業、研究機構、顧問、中小企業和大型企業來說都是有益且具有成本效益的。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

調查範圍

  • 2020 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
  • 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測細分市場和區域分析（包括國家）
  • 公司概況（尤其是趨勢）、財務資訊和關鍵發展

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

5. 全球寵物疫苗市場（依動物類型）

  • 介紹
  • 狗
  • 貓
  • 馬
  • 鳥類
  • 其他

6. 全球寵物疫苗市場（依疫苗接種類型）

  • 介紹
  • 核心疫苗
  • 非核心疫苗
  • 其他

7. 全球寵物疫苗市場（依接種方式）

  • 介紹
  • 注射疫苗
  • 鼻內疫苗
  • 口服疫苗

8. 全球寵物疫苗市場（依分銷管道）

  • 介紹
  • 獸醫診所
  • 零售藥局
  • 線上平台
  • 獸醫診所

9. 全球寵物疫苗市場（按地區）

  • 介紹
  • 北美洲
    • 依動物類型
    • 透過接種疫苗
    • 按接種方式
    • 按分銷管道
    • 按國家
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依動物類型
    • 透過接種疫苗
    • 按接種方式
    • 按分銷管道
    • 按國家
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依動物類型
    • 透過接種疫苗
    • 按接種方式
    • 按分銷管道
    • 按國家
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 其他
  • 中東和非洲
    • 依動物類型
    • 透過接種疫苗
    • 按接種方式
    • 按分銷管道
    • 按國家
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依動物類型
    • 透過接種疫苗
    • 按接種方式
    • 按分銷管道
    • 按國家
      • 中國
      • 日本
      • 印度
      • 韓國
      • 台灣
      • 其他

第10章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第11章：公司簡介

  • Zoetis
  • Merck Animal Health（MSD）
  • Elanco
  • Boehringer Ingelheim
  • Virbac
  • Vetoquinol
  • Ceva Sante Animale
  • Tianjin Ringpu Bio-Technology

第12章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061611148

The Global Pet Vaccine Market is expected to USD 1,426 billion in 2025 to USD 1,925 billion in 2030, at a CAGR of 6.19%.

The global pet vaccine market is poised for steady growth, driven by rising pet ownership, increasing awareness of pet health, and the growing prevalence of zoonotic diseases. Pet vaccines are essential for maintaining animal immunity and safeguarding community health, particularly against diseases like rabies. Technological advancements, supportive government initiatives, and increased R&D investments further propel market expansion. The canine vaccine segment, especially injectable vaccines, is expected to see substantial growth due to their effectiveness in preventing infectious diseases.

Market Growth Drivers

Rising Pet Ownership and Disease Prevalence

The surge in pet ownership, particularly among millennials, drives demand for pet vaccines as owners prioritize animal health. The increasing prevalence of zoonotic diseases, such as rabies, underscores the need for regular vaccinations. Rabies, transmitted primarily by dogs, remains a significant global health concern, with high incidence in regions like Southeast Asia. The effectiveness of vaccines in preventing such diseases, coupled with growing public awareness and animal welfare campaigns, fuels market growth.

Technological Advancements and Government Support

Innovations in vaccine development enhance efficacy and safety, boosting market adoption. Positive government initiatives, including subsidies and awareness programs, encourage pet vaccinations, particularly in regions with high disease burdens. Rising R&D expenditure supports the introduction of advanced vaccines, addressing emerging health challenges and expanding market potential. The focus on injectable vaccines, administered subcutaneously or intramuscularly, highlights their role in stimulating robust immune responses, making them a cornerstone of veterinary medicine.

Canine Vaccine Market Expansion

The canine vaccine segment is anticipated to grow significantly, driven by the need to combat common diseases like rabies, canine parvovirus, and leptospirosis. Injectable vaccines, designed to protect against infectious pathogens, are widely used due to their reliability and ease of administration by veterinary professionals. The global demand for rabies vaccines, particularly in low- and middle-income countries, further bolsters this segment, supported by organizations like UNICEF ensuring affordable supply.

Geographical Outlook

The United States dominates the North American pet vaccine market, driven by a large pet population and high pet ownership rates, particularly among millennial households. The country's focus on pet health, linked to benefits like improved human well-being, supports demand for vaccines. The substantial dog and cat population requires regular vaccinations, creating a robust market. Other North American countries, like Canada, also contribute through growing pet adoption and awareness. The Asia-Pacific region is expected to witness rapid growth, fueled by increasing pet ownership and government-backed health initiatives in countries like India and China.

The pet vaccine market is set for steady growth, propelled by rising pet ownership, zoonotic disease prevalence, and advancements in vaccine technology. The canine segment, particularly injectable vaccines, leads due to its critical role in disease prevention. The United States remains a key market, while Asia-Pacific shows strong growth potential. Government support and R&D investments further enhance market prospects. As pet health awareness grows, the demand for effective vaccines is expected to rise, ensuring sustained market expansion.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Pet Vaccine Market Segmentation:

By Animal Type

  • Canine
  • Feline
  • Equine
  • Avian
  • Others

By Vaccination

  • Core Vaccines
  • Non-Core Vaccines
  • Others

By Administration

  • Injectable Vaccines
  • Intranasal Vaccines
  • Oral Vaccines

By Distribution Channel

  • Veterinary Clinics
  • Retail Pharmacies
  • Online Platforms
  • Animal Hospitals

By Geography

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL PET VACCINE MARKET BY ANIMAL TYPE

  • 5.1. Introduction
  • 5.2. Canine
  • 5.3. Feline
  • 5.4. Equine
  • 5.5. Avian
  • 5.6. Others

6. GLOBAL PET VACCINE MARKET BY VACCINATION

  • 6.1. Introduction
  • 6.2. Core Vaccines
  • 6.3. Non-Core Vaccines
  • 6.4. Others

7. GLOBAL PET VACCINE MARKET BY ADMINISTRATION

  • 7.1. Introduction
  • 7.2. Injectable Vaccines
  • 7.3. Intranasal Vaccines
  • 7.4. Oral Vaccines

8. GLOBAL PET VACCINE MARKET BY DISTRIBUTION CHANNEL

  • 8.1. Introduction
  • 8.2. Veterinary Clinics
  • 8.3. Retail Pharmacies
  • 8.4. Online Platforms
  • 8.5. Animal Hospitals

9. GLOBAL PET VACCINE MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Animal Type
    • 9.2.2. By Vaccination
    • 9.2.3. By Administration
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Animal Type
    • 9.3.2. By Vaccination
    • 9.3.3. By Administration
    • 9.3.4. By Distribution Channel
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Animal Type
    • 9.4.2. By Vaccination
    • 9.4.3. By Administration
    • 9.4.4. By Distribution Channel
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Animal Type
    • 9.5.2. By Vaccination
    • 9.5.3. By Administration
    • 9.5.4. By Distribution Channel
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Animal Type
    • 9.6.2. By Vaccination
    • 9.6.3. By Administration
    • 9.6.4. By Distribution Channel
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Taiwan
      • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Zoetis
  • 11.2. Merck Animal Health (MSD)
  • 11.3. Elanco
  • 11.4. Boehringer Ingelheim
  • 11.5. Virbac
  • 11.6. Vetoquinol
  • 11.7. Ceva Sante Animale
  • 11.8. Tianjin Ringpu Bio-Technology

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations